Oesophageal Cancer Trial, Recruiting (NCT06755866)

Oesophageal Cancer Trial, Recruiting NCT06755866 Sponsor: Yunnan Cancer Hospital Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06755866 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older.
People who have been newly and first-time diagnosed with a specific type of oesophageal (food pipe) cancer called squamous cell carcinoma, confirmed by a tissue biopsy.
People whose cancer is at a certain stage — either an intermediate stage that has spread to nearby lymph nodes, or a more advanced stage involving the chest portion of the food pipe or the area where the food pipe meets the stomach (confirm with trial site for exact staging details).
People who have no medical reasons preventing them from having an MRI scan.

Who may not be able to join:

People who have another type of primary (original) cancer elsewhere in the body.
People whose medical scan images are not clear enough to meet the required quality standards for the study.
People who are unable or unwilling to cooperate with the required examinations and scans.
People who have previously received chemotherapy or radiation therapy for their cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lianhua Ye, Ethics Committee of Yunnan Provincial Cancer Hospital

Phone: 17390212095

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06755866

Sponsor: Yunnan Cancer Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: 17390212095

More information: https://clinicaltrials.gov/study/NCT06755866

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older.
People who have been newly and first-time diagnosed with a specific type of oesophageal (food pipe) cancer called squamous cell carcinoma, confirmed by a tissue biopsy.
People whose cancer is at a certain stage — either an intermediate stage that has spread to nearby lymph nodes, or a more advanced stage involving the chest portion of the food pipe or the area where the food pipe meets the stomach (confirm with trial site for exact staging details).
People who have no medical reasons preventing them from having an MRI scan.

Who may not be able to join:

People who have another type of primary (original) cancer elsewhere in the body.
People whose medical scan images are not clear enough to meet the required quality standards for the study.
People who are unable or unwilling to cooperate with the required examinations and scans.
People who have previously received chemotherapy or radiation therapy for their cancer.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yunnan Cancer Hospital

Registry

ClinicalTrials.gov

Start date

26 November 2024

Est. completion

31 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Tumor response assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov